Randomized clinical trial: pharmacokinetics and safety of multimatrix mesalamine for treatment of pediatric ulcerative colitis
Carmen Cuffari,1 David Pierce,2 Bartosz Korczowski,3 Krzysztof Fyderek,4 Heather Van Heusen,5 Stuart Hossack,6 Hong Wan,5 Alena YZ Edwards,7 Patrick Martin5 1Department of Pediatrics, Division of Pediatric Gastroenterology and Nutrition, The Johns Hopkins University School of Medicine, Baltimore, M...
Main Authors: | Cuffari C, Pierce D, Korczowski B, Fyderek K, Van Heusen H, Hossack S, Wan H, Edwards AY, Martin P |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-02-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/randomized-clinical-trial-pharmacokinetics-and-safety-of-multimatrix-m-peer-reviewed-article-DDDT |
Similar Items
-
Ulcerative colitis: Al-gassim experience
by: Contractor Qais, et al.
Published: (2004-01-01) -
Enteric infections complicating ulcerative colitis
by: Dejan Micic, et al.
Published: (2018-07-01) -
New developments in ulcerative colitis: latest evidence on management, treatment, and maintenance
by: Kartikeya Tripathi, et al.
Published: (2019-04-01) -
Ulcerative Colitis and Neopterin: Related?
by: Beşir Kesici, et al.
Published: (2019-04-01) -
Update on the Management of Ulcerative Colitis
by: Nasser Ebrahimi Daryani, et al.
Published: (2012-06-01)